Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (17)
  • 2024 (22)
  • 2023 (47)
  • 2022 (65)
  • 2021 (57)
  • 2020 (10)
  • 2019 (7)
  • 2018 (1)
  • 2017 (2)
  • 2003 (1)

Subject

  • Drug Trafficking (4010)
  • Synthetic drugs (1064)
  • Guns/Weapons (989)
  • OCDETF/Task Force (810)
  • Fake Pills (654)
  • Arrests/Convictions - Major (603)
  • Guilty Plea (529)
  • Seizures (Drugs/Property) (456)
  • Prescription Drugs (364)
  • Overdose (321)
  • Major Law Enforcement Operation (267)
  • Take Back Day (246)
  • Diversion Division (242)
  • Task Forces/Task Force Officers (230)
  • Money Laundering (203)
  • Gangs (196)
  • Outreach/Drug Prevention (184)
  • Fentanyl Awareness (152)
  • One Pill Can Kill (110)
  • HIDTA (103)
  • Press Conferences (68)
  • Narcoterrorism (53)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (50)
  • Public and Media Affairs - also see Congressional Affairs (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Fentanyl Free America (12)
  • Intergovernmental Affairs (9)
  • Other (8)
  • Campaigns (7)
  • Critical Incident (6)
  • Counterfeit Pills (5)
  • Intelligence Division - Intelligence Products (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Pharmaceuticals/Pharmacists/Physicians (224)
  • Scam Calls (5)

Drug Name

  • Oxycodone (47)
  • Opioids (45)
  • Fentanyl (26)
  • Hydromorphone (12)
  • Synthetic Opioids (12)
  • Benzodiazepines (7)
  • Morphine (7)
  • Ketamine (3)
  • Methadone (3)
  • Methamphetamine (3)
  • Steroids (3)
  • Amphetamines (2)
  • Cocaine (2)
  • GHB (1)
  • Heroin (1)

Field Division

  • Washington, DC (35)
  • St. Louis (32)
  • New York (21)
  • Chicago (19)
  • Miami (16)
  • Atlanta (12)
  • Headquarters (11)
  • New Jersey (11)
  • El Paso (10)
  • Dallas (9)
  • Houston (7)
  • San Francisco (7)
  • Seattle (7)
  • Louisville (5)
  • New England (5)
  • New Orleans (5)
  • San Diego (5)
  • Los Angeles (4)
  • Rocky Mountain (3)
  • Omaha (2)
  • Phoenix (2)
  • Philadelphia (1)
Clear All Results
PRESS RELEASE

Bluefield Doctor Sentenced to Federal Prison on Misbranding Charge

May 13, 2021
ABINGDON, Va. – A family medicine physician in Bluefield, Virginia, was sentenced yesterday to one month in prison on a charge of misbranding Schedule II controlled substances to three individuals, two of whom his office staff called “back door patients.” According to court documents, between December 2014 and January 2016...
May 13, 2021
PRESS RELEASE

Dark Web Vendor of Opioids and Counterfeit U.S. Currency Pleads Guilty

May 12, 2021
ALEXANDRIA, Va. – A Utica, New York man pleaded guilty yesterday to charges relating to his sale of over $1.2 million in opioid pills and counterfeit U.S. currency on multiple dark web criminal marketplaces. According to court documents, from around October 2016 through February 2021, Albie Pagan, 65, operated under...
May 12, 2021
PRESS RELEASE

Albuquerque company agrees to $240,000 settlement relating to Controlled Substances Act claims

March 30, 2021
ALBUQUERQUE, N.M. – Acting U.S. Attorney for the District of New Mexico Fred J. Federici has announced that Albuquerque Health Services (AHS) has agreed to a $240,000 settlement relating to civil claims brought by the Department of Justice on behalf of the United States Drug Enforcement Administration (DEA). AHS operates...
March 30, 2021
PRESS RELEASE

Prison healthcare company agrees to $215,000 settlement relating to Controlled Substances Act claims

March 30, 2021
ALBUQUERQUE, N.M. – Acting U.S. Attorney for the District of New Mexico Fred J. Federici has announced that Centurion Correctional Healthcare New Mexico has agreed to a $215,000 settlement relating to civil claims brought by the Department of Justice on behalf of the United States Drug Enforcement Administration (DEA). Centurion...
March 30, 2021
PRESS RELEASE

San Antonio Physician Agrees to Pay $350,000 to Resolve Allegations that he Pre-Signed Prescriptions and Issued Prescriptions Without Appropriate Examinations

March 09, 2021
SAN ANTONIO - Doctor Hugo A. Rojas, owner of Hugo A. Rojas, M.D., P.A., and Family Clinics of San Antonio, has agreed to pay $350,000.00 under a civil settlement to resolve allegations he violated certain provisions of the Controlled Substances Act (CSA) and the False Claims Act (FCA), announced Drug...
March 09, 2021
PRESS RELEASE

DEA Warning: Scammers Impersonating DEA Agents

March 03, 2021
WASHINGTON – The Drug Enforcement Administration is warning the public of a widespread fraud scheme in which telephone scammers impersonate DEA agents in an attempt to extort money or steal personal identifiable information. A new public service announcement aims to raise awareness that DEA will never phone demanding money or...
March 03, 2021
PRESS RELEASE

Justice Department files lawsuit against Creve Coeur pharmacist for Controlled Substances Act violations

February 24, 2021
ST. LOUIS – In a complaint filed February 23, 2021, by the U.S. Attorney’s Office for the Eastern District of Missouri, the government alleges Elizabeth Dembo unlawfully dispensed controlled substances to patients during her time as the pharmacist-in-charge of Olive Street Pharmacy, LLC. The retail pharmacy is located in the...
February 24, 2021
PRESS RELEASE

Pharmaceutical Distributor Vistapharm, Inc. Agrees To Pay $325,000 To Resolve Alleged Violations Of The Controlled Substances Act

February 02, 2021
TAMPA, Fla. - Vistapharm, Inc. has agreed to pay the United States $325,000 to resolve allegations that Vistapharm violated the Controlled Substances Act (CSA) by failing to maintain records required by the CSA. In addition to paying a civil penalty, Vistapharm has agreed to sign separately a Memorandum of Agreement...
February 02, 2021
PRESS RELEASE

New COVID-19 Vaccine will bring opportunities for Fraud

December 18, 2020
BEAUMONT, Texas - With millions of people waiting for their turn to get the new COVID vaccine, it is expected that scammers will use that opportunity to prey on those willing to pay for it. “Since the beginning of the pandemic, we’ve seen fraudsters taking advantage of public programs and...
December 18, 2020
PRESS RELEASE

Odessa pharmacy and owner to pay $320,000 in civil penalties

December 02, 2020
EL PASO, Texas -- Odessa pharmacy Town & Country Drug, Inc. (Town & Country) and its owner, pharmacist Gary Warren, have entered into a civil settlement with the United States that requires them to pay $320,000 in civil penalties to resolve allegations that they violated certain provisions of the Controlled...
December 02, 2020
Showing 201 - 210 of 229 results

Pagination

  • First page «
  • Previous page ‹
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Current page 21
  • Page 22
  • Page 23
  • Next page ›
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster